{
    "2018-05-15": [
        [
            {
                "time": "",
                "original_text": "正大天晴安罗替尼获批 肺癌靶向药市场谁是强者？",
                "features": {
                    "keywords": [
                        "安罗替尼",
                        "获批",
                        "肺癌",
                        "靶向药",
                        "市场"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业17年报18年一季报总结:增速回升,内部分化,关注创新、优质仿制药、连锁药店、医药商业",
                "features": {
                    "keywords": [
                        "医药生物",
                        "年报",
                        "季报",
                        "增速回升",
                        "内部分化",
                        "创新",
                        "仿制药",
                        "连锁药店",
                        "医药商业"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}